To the best of our knowledge, this is the first report that links Fgf6 expression in skeletal muscles to metabolic disorders, providing new insight into the role the environment-gene interaction network plays in the pathogenesis of obesity, and this insight might aid in the development of prevention and treatment strategies for metabolic diseases. The gene discussed is FGF6; the disease is obesity due to melanocortin 4 receptor deficiency.